Long non‐coding RNA MALAT1 regulates angiogenesis following oxygen‐glucose deprivation/reoxygenation

• Published in: Journal of cellular and molecular medicine 2019-04, Vol.23 (4), p.2970-2983
• Main Authors: Wang, Chengya, Qu, Youyang, Suo, Rui, Zhu, Yulan
• Format: Article
• Language: English
• Subjects: Adenocarcinoma; Angiogenesis; Animals; Antibodies; Apoptosis; Binding sites; Brain; Brain Ischemia - complications; Carotid arteries; Cell adhesion & migration; Cell culture; Cell cycle; Cell Hypoxia; Cell Movement; endothelial cells; Endothelium, Vascular - metabolism; Endothelium, Vascular - pathology; Experiments; Gene expression; Glucose; Glucose - deficiency; Hybridization; Hypoxia; ischaemia/reperfusion; Laboratory animals; Lipoxygenase; Lung cancer; Lungs; MALAT1; Male; Metastases; Mice; Mice, Inbred C57BL; Neovascularization, Pathologic - etiology; Neovascularization, Pathologic - metabolism; Neovascularization, Pathologic - pathology; Non-coding RNA; Original; Oxygen; Oxygen - metabolism; oxygen‐glucose deprivation/reoxygenation; Phosphorylation; Reperfusion Injury - complications; Ribonucleic acid; RNA; RNA, Long Noncoding - genetics; Scratching; Signal Transduction; Stat3 protein; Stroke; Transcription factors; Transducers; Vascular endothelial growth factor; Veins & arteries
• ISSN: 1582-1838; 1582-4934; 1582-4934
• DOI: 10.1111/jcmm.14204

Long non‐coding RNAs (lncRNAs) have been identified as playing critical roles in multiple diseases. However, little is known regarding their roles and mechanisms in post‐stroke angiogenesis. Our studies focused on deciphering the functional roles and the underlying mechanisms of the lncRNA metastasis‐associated lung adenocarcinoma transcript 1 (MALAT1) in the process of angiogenesis following oxygen‐glucose deprivation/reoxygenation (OGD/R). We characterized the up‐regulation of MALAT1 expression in the process of angiogenesis after hypoxic injury in vivo and in vitro. We further showed that compared with the empty vector, MALAT1 knockdown had significantly reduced the capacity for angiogenesis, which was measured by 3‐(4,5‐dimethylthiazol‐2‐yl)‐2,5‐diphenyltetrazolium (MTT), scratching, cell cycle and immunofluorescent staining. Thus, our findings suggest that MALAT1 may mediate proangiogenic function in OGD/R. To further explore the potential mechanisms, we used lentiviruses expressing shMALAT1 and empty vector; the results revealed that shMALAT1 reduced the expression of 15‐lipoxygenase 1 (15‐LOX1), vascular endothelial growth factor (VEGF) and the phosphorylation of signal transducers and activators of transcription 3 (pSTAT3). Taken together, our results are the first to propose that MALAT1 may regulate angiogenesis through the 15‐LOX1/STAT3 signalling pathway, and they may provide a critical target for the treatment of hypoxic injury and an avenue for therapeutic angiogenesis.